Vanguard FTSE Europe ETF (NYSEARCA: VGK), has emerged as the best-performing Vanguard index fund so far this year ...

EUROPEAN shares rebounded on Tuesday from a two-month low touched in the previous session, while the market braced for an ...

European shares rebounded on Tuesday from a two-month low touched in the previous session, while the market braced for an ...

US President Donald Trump is set to unveil reciprocal tariffs on Wednesday, with ongoing uncertainties surrounding his ...

Novo Nordisk’s stocks experienced the sharpest monthly decline since July 2002 due to growing competition and several ...

As Novo Nordisk A/S shares head for their worst month in more than two decades, the days when the Danish drugmaker was valued ...

As Novo Nordisk A/S shares head for their worst month in more than two decades, the days when the Danish drugmaker was valued at more than $600 billion are becoming a distant memory.

European companies that are spending big on generative artificial intelligence need to start showing returns on their massive outlays by next year, or risk investors losing patience after they paid ...

Danish drugmaker Novo Nordisk has been dethroned by German software giant SAP as Europe’s most valuable company. SAP has ...

Novo Nordisk shares are experiencing a significant decline amidst intensified investor concerns over its competitiveness in ...